Filter
2531
Filtered Results: 2531
Text search:
National
Centre
for
Disease
Control,
India
Featured
Recommendations
221
New Publications
664
Language
Document type
No document type
1416
Studies & Reports
515
Guidelines
306
Manuals
136
Strategic & Response Plan
62
Fact sheets
34
Training Material
27
Situation Updates
17
Resource Platforms
9
Infographics
5
Online Courses
2
Brochures
1
App
1
Countries / Regions
India
398
Global
140
Nepal
73
Bangladesh
42
Asia
41
South–East Asia Region
37
South Africa
32
Latin America and the Carribbean
32
Kenya
31
Myanmar / Burma
31
Africa
29
Nigeria
28
Ethiopia
25
Uganda
20
Western and Central Europe
20
Malawi
19
Syria
18
Philippines
16
Indonesia
16
Brazil
14
Tanzania
13
Mozambique
13
Sierra Leone
12
Zambia
12
Liberia
11
Senegal
11
Pakistan
11
Ukraine
11
Russia
11
Zimbabwe
9
Rwanda
9
Eastern Europe
9
USA
8
Afghanistan
8
Thailand
8
Colombia
8
Ghana
7
Cambodia
7
Namibia
7
West and Central Africa
7
Congo, Democratic Republic of
6
Haiti
6
Sri Lanka
6
East and Southern Africa
6
Eastern Europe and Central Asia
6
Venezuela
6
Guinea
5
South Sudan
5
China
5
Ecuador
4
Bolivia
4
Angola
4
Yemen
4
Middle East and North Africa
4
Western Pacific Region
4
Paraguay
4
Somalia
3
Iraq
3
Jordan
3
Argentina
3
Peru
3
Timor Leste/ East Timor
3
Vietnam
3
North America
3
Mali
2
Cameroon
2
Lebanon
2
Sudan
2
Benin
2
Central African Republic
2
Botswana
2
El Salvador
2
Libya
2
Madagascar
2
Lesotho
2
Mexico
2
Chile
2
Other region
2
Bhutan
2
Albania
2
Tajikistan
2
Moldova
2
Georgia
2
Bosnia and Herzegovina
2
Burkina Faso
1
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
Niger
1
Germany
1
Egypt
1
Malaysia
1
Papua New Guinea
1
Dominican Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Honduras
1
Greece
1
Palestine
1
North Korea
1
Italy
1
Armenia
1
Mongolia
1
Laos
1
Canada
1
Qatar
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
853
Clinical Guidelines
287
Public Health
179
Women & Child Health
143
Key Resources
104
Capacity Building
34
Pharmacy & Technologies
31
Annual Report MEDBOX
1
Toolboxes
TB
208
COVID-19
206
Mental Health
199
HIV
191
Planetary Health
97
AMR
89
NTDs
86
Caregiver
78
Disability
72
NCDs
72
Rapid Response
65
Global Health Education
62
Health Financing Toolbox
39
Pharmacy
37
Refugee
32
Conflict
30
Natural Hazards
25
Ebola
22
Polio
22
Cholera
15
Specific Hazards
11
Zika
7
Social Ethics
6
Health Financing
2
South Sudan
1
Background:Neonatal mortality accounts for 43% of global under-five deaths and is decreasing more slowly than maternal or child mortality. Donor funding has increased for maternal, newborn, and chil...
A series of information sheets to help empower communities and strengthen health systems
This series of information sheets introduces health literacy, its
relevance to public policy, and the ways it can be used to inform
the promotion of good health, the prevention and management
of communicab...
Traditional food markets play important economic, cultural, and social role and are sources of livelihood for millions of people in urban and rural areas. The manual Five keys for safer traditional ...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination...
Background
Cardiovascular diseases (CVDs) are one of the global leading causes of concern due to the rising prevalence and consequence of mortality and disability with a heavy economic burden. The objective of the current study was to analyze the t...
More than 700 000 people lose their life to suicide every year. The world is not on track to reach the 2030 suicide reduction targets. WHO advocates for countries to take action to prevent suicide, ideally through a comprehensive ... suicide prevention strategy. Governments and communities can contribute to suicide prevention by implementing LIVE LIFE – WHO’s approach to starting suicide prevention so that countries can build on it further to develop a comprehensive national suicide prevention strategy. The guide is for all countries, with or without a national suicide prevention strategy; national or local focal points for suicide prevention, mental health, alcohol or NCDs; and community stakeholders with a vested interest or who may already be engaged in implementing suicide prevention activities.
Excecutive Summary available in English, French, Arabic, Chinese, Russian and Spanisch here:
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and thr...
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access ... clarity. The publication of the RECOVERY and REMAP-CAP randomised controlled trials triggered this guideline update, resulting in a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19.
Prior recommendations: (a) A recommendation not to use ivermectin in patients with covid-19, regardless of disease severity, except in the context of a clinical trial; (b) a strong recommendation against the use of hydroxychloroquine in patients with covid-19, regardless of disease severity; (c) a strong recommendation against the use of lopinavir-ritonavir in patients with covid-19, regardless of disease severity; (d) a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19; (e) a conditional recommendation against systemic corticosteroids in patients with non-severe covid-19; and (f) a conditional recommendation against remdesivir in hospitalised patients with covid-19.
The 20th century was a period of unprecedented ecological change, with dramatic reductions in natural ecosystems and biodiversity and equally dramatic increases in people and domestic animals. Never before have so many animals been kept by so many people—and never before have so many opportunities...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effectiv...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have de...
Recently, a renewed interest in large-scale community health worker (CHW) programs has been seen globally. This renewal provides an opportune moment to take stock of issues and challenges such programs face and what can be done to make them as effective as possible. With this in mind, this manual is...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable ... (NCDs) worldwide. There is currently
an epidemiological transition on the continent, where NCDs is projected
to outpace communicable diseases within the current decade. Unchecked
increases in CVD risk factors have contributed to the growing burden of three
major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age
standardized disability-adjusted life years (DALYs) due to hypertensive heart
disease (HHD) were recorded in Africa. The contributory causes of heart failure
are changing—whilst HHD and cardiomyopathies still dominate, ischemic
heart disease is rapidly becoming a significant contributor, whilst rheumatic
heart disease (RHD) has shown a gradual decline. In a continent where health
systems are traditionally geared toward addressing communicable diseases,
several gaps exist to adequately meet the growing demand imposed by CVDs.
Among these, high-quality research to inform interventions, underfunded
health systems with high out-of-pocket costs, limited accessibility and
affordability of essential medicines, CVD preventive services, and skill
shortages. Overall, the African continent progress toward a third reduction
in premature mortality come 2030 is lagging behind. More can be done in
the arena of effective policy implementation for risk factor reduction and
CVD prevention, increasing health financing and focusing on strengthening
primary health care services for prevention and treatment of CVDs, whilst
ensuring availability and affordability of quality medicines. Further, investing
in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on
interventions. This review summarizes the current CVD burden, important
gaps in cardiovascular medicine in Africa, and further highlights priority
areas where efforts could be intensified in the next decade with potential
to improve the current rate of progress toward achieving a 33% reduction
in CVD mortality.
Pneumonia kills more children than any other illness – more than AIDS, malaria and measles combined. Over 2 million children die from pneumonia each year, accounting for almost 1 in 5 under five deaths worldwide. Yet, little attention is paid to t...
The WHO Global strategy on human resources for health: workforce 2030 encourages development partners and global health initiatives to leverage their support to health systems in countries to sustainably strengthen the health workforce. To assess th...
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer ... under the elimination threshold with respect to cervical
cancer incidence. As part of WHO’s approach to cervical cancer control, availability of high quality,
affordable medical devices for HPV screening, and treatment of precancerous
lesions in low resource settings is indispensable.
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
